Home » Topics » BioWorld Science

BioWorld Science
RSS

A simple method for the synthesis of isoxazole derivatives with in vitro antitumor activity

Jan. 12, 2022

Neogene licenses portfolio of TCRs targeting KRAS and TP53 mutations from NCI

Jan. 12, 2022

G3PP is a therapeutic target for age-related metabolic diseases

Jan. 12, 2022

ABL and Sanofi enter collaboration and license agreement for ABL-301

Jan. 12, 2022

Dren Bio and Pfizer collaborate to discover and develop bispecific antibodies for cancer

Jan. 12, 2022

VCAM-1-targeting polyelectrolyte complex enhances therapeutic efficacy of miR-92a inhibitors in vivo

Jan. 12, 2022

PostEra and Pfizer expand strategic collaboration

Jan. 12, 2022

REVTx-99 demonstrates in vitro antiviral activity against SARS-CoV-2

Jan. 12, 2022

Methamphetamine harnessed for good in BBB transport

Jan. 12, 2022

CD6-ALCAM pathway is a therapeutic target in SLE

Jan. 12, 2022

Popular Stories

Today's news in brief
BioWorld
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...
CROI 2026 highlights depression and cognitive vulnerability in HIV
BioWorld
The effects of aging pose an additional challenge for people with HIV due to the neurological and psychological consequences that persist despite antiretroviral...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 24, 2026
University of Southern California reports new MAPT aggregation inhibitors
BioWorld Science
The University of Southern California has identified (2-oxo-2H-chromen-3-yl) scaffold-based carboxamide analogues acting as potent microtubule-associated protein...